Healthcare

Sanviva

Sanviva is a European medical device distribution network with a portfolio covering product categories such as wound care, ostomy care and in vitro diagnostics.
 
The network combines local sales, distribution and market expertise to offer medical device suppliers a single point of access to healthcare markets across Europe.

 

Headquarters: Denmark

CEO: Andreas von Scholten

Website: https://www.sanviva.com

Responsible partner: Jacob Drakenberg Walberg

Our investment

  • Sanviva is built on long-standing exclusive supplier relationships, strong local presence and expertise in regulatory requirements and public tenders.

  • Through Sanviva, medical device suppliers benefit from local expertise and established relationships without having to navigate each market separately, while healthcare providers and patients gain access to the latest innovations.

  • Sanviva will continue to expand its product portfolio and geographic presence, building a pan-European distribution platform.

2026

Axcel
investment

30m

EUR Revenue

Healthcare

Sanviva

Sanviva is a European medical device distribution network with a portfolio covering product categories such as wound care, ostomy care and in vitro diagnostics.
 
The network combines local sales, distribution and market expertise to offer medical device suppliers a single point of access to healthcare markets across Europe.

 

Our investment

  • Sanviva is built on long-standing exclusive supplier relationships, strong local presence and expertise in regulatory requirements and public tenders.

  • Through Sanviva, medical device suppliers benefit from local expertise and established relationships without having to navigate each market separately, while healthcare providers and patients gain access to the latest innovations.

  • Sanviva will continue to expand its product portfolio and geographic presence, building a pan-European distribution platform.

Headquarters: Denmark

CEO: Andreas von Scholten

Website: https://www.sanviva.com

Responsible partner: Jacob Drakenberg Walberg

2026

Axcel investment

30m

EUR Revenue